The Aptus Endosystems management team includes:
Jeff Elkins, President and Chief Executive Officer
Lee Bolduc, Vice President of Engineering, CTO, Co-Founder
David H. Deaton, M.D., Chief Medical Consultant
Tedd Hinton, Senior Director of Manufacturing
Deepak Srikant, Director of Clinical Marketing
Jeff Elkins, President and Chief Executive Officer
Mr. Jeff Elkins joined Aptus Endosystems from FlowMedica, a commercial stage company focused on endovascular treatments for acute kidney injury, where he was Chief Executive Officer until the company's acquisition by AngioDynamics (NASDAQ: ANGO).
Prior to this, Mr. Elkins held various positions within Medtronic Vascular's Endovascular Unit, including Business Unit Manager, Vice President of R&D and Vice President of Business Development. During his tenure at Medtronic, Mr. Elkins oversaw operations pertaining to the TALENT and ANEURX AAA & TAA Endograft platforms, including the successful commercial launches of both product lines in both the U.S. and internationally. Mr. Elkins joined Medtronic via the acquisition of World Medical, the company that originally developed the TALENT AAA platform, where he was Vice President of Operations and Chief Technical Officer. Mr. Elkins joined World Medical after a series of operating and R&D roles at Cordis Endovascular Systems, Cordis Corporation and Haemonetics.
Mr. Elkins holds a BS in Mechanical Engineering from the University of Massachusetts, Amherst.
Lee Bolduc, Vice President of Engineering, CTO, Co-Founder
Prior to co-founding Aptus Endosystems, Mr. Bolduc was Vice President of Engineering at Salient Interventional Systems, where he led the engineering effort in the development of a catheter-based neuroperfusion system, bringing the project from concept to a successful OUS clinical study within one year. Prior to joining Salient, Mr. Bolduc was a Director of Engineering at Heartport, a venture financed medical technology company that helped to pioneer the field of minimally invasive cardio-thoracic surgery. At Heartport he led the automated anastomosis and beating heart programs prior to the company's acquisition by Johnson & Johnson.
Mr. Bolduc previously held positions in engineering and development at Origin MedSystems, (acquired by Guidant), designing and developing laparoscopic instruments, and at Omni-Trac Surgical, where he designed and developed surgical instruments and retractor systems. Mr. Bolduc has 16 years of experience in the medical device industry, is listed as an inventor on 61 issued United States patents and holds a B.S. Degree in Mechanical Engineering.
David H. Deaton, M.D., Chief Medical Consultant
David Deaton is Chief of Endovascular Surgery and Associate Professor of Surgery at Georgetown University Hospital in Washington, D.C.. Dr. Deaton has over 15 years experience in the practice vascular surgery. He was an original principle investigator in the earliest endovascular aneurysm repair device trials and has continued to participate in numerous vascular and endovascular device developments and clinical trials over the past 10 years of his clinical practice, with particular interest in aortic, carotid and lower extremity diseases.
Dr. Deaton is a graduate of Duke University School of Medicine. He completed his internship and surgical residency at the Hospital of the University of Pennsylvania and his fellowship at the University of California, Los Angeles. He is board certified in both surgery and vascular surgery and is an active member of the Society for Vascular Surgery and the Peripheral Vascular Surgery Society.
Tedd Hinton, Senior Director of Manufacturing
Mr. Tedd Hinton has over 20 years of experience in Operations and Manufacturing roles, the last 10+ years in the medical device industry. Prior to joining Aptus, Mr. Hinton spent 5 years as Senior Director of Operations at Paracor Medical Inc., a company specializing in development of products for the treatment of heart failure. In this role, he was responsible for leading all manufacturing activities. From 1999 thru 2004, Mr. Hinton was Director of Manufacturing Engineering at Coalescent Surgical, which was acquired by Medtronic. While at Coalescent, Mr. Hinton developed many of the precision manufacturing tools and methods for the "U-CLIP" and "SPYDER" anastomotic devices as well as other Coalescent products and was instrumental in establishing Coalescent's Empalme, Mexico manufacturing facility.
Prior to joining Coalescent, Mr. Hinton spent 11 years in the hard disk drive industry where he held several Manufacturing and Product Engineering roles. Mr. Hinton holds a B.S. degree in Mechanical Engineering from California Polytechnic State University, San Luis Obispo, CA.
Deepak Srikant, Director of Clinical Marketing
Mr. Deepak Srikant is Director of Clinical Marketing at Aptus Endosystems with responsibility for strategic marketing, market development, and clinical education and support. Mr. Srikant has 15 years of experience spanning multiple functional areas in the medical device industry including manufacturing, product development, clinical research, and marketing.
Mr. Srikant joined Aptus from Cordis, J&J where he developed and executed marketing strategy and tactics for key products in the endovascular franchise. Before that, he served as a strategy consultant at Deloitte Consulting, where he advised clients in the life sciences industry. He has also held roles in strategic marketing and specialty product sales at Roche Pharmaceuticals.
Prior to the pharmaceutical industry, Mr. Srikant was involved with the TALENT AAA clinical study administration at Medtronic Vascular. Mr. Srikant joined Medtronic via the acquisition of World Medical, where he was responsible for providing technical support for the TALENT AAA Stent Graft System and developing physician relations. Mr. Srikant began his career in manufacturing and product development with Cordis Endovascular Systems where he helped launch embolic coils for the interventional neuroradiology market.
Mr. Srikant holds a B.S. in Mechanical Engineering from Rensselaer Polytechnic Institute and an M.B.A. from the Yale School of Management.
Dian Georgia, Director of Finance
Ms. Dian Georgia joined Aptus in November 2006. Ms. Georgia brings to Aptus over 20 years of diversified financial experience in corporate and manufacturing environments in both the medical device and biotechnology industry. She has participated in the successful integration of several acquisitions.
Prior to joining Aptus, Ms. Georgia was Controller at Solexa, Inc. a company focused on DNA analysis, where she was responsible for the integration of Solexa LLC with Lynx Therapeutics following their merger. Prior to Solexa, Ms. Georgia held financial positions with ACLARA BioSciences Inc. (through its acquisition by Virologic, Inc./Monogram BioSciences), ArthroCare Corp., Symphonix Devices and Target Therapeutics (acquired by Boston Scientific).
Burt Goodson, Director, Scientific and Regulatory Affairs
Mr. Burt Goodson is Director of Scientific and Regulatory Affairs at Aptus Endosystems. he is a 15 year veteran of the medical device industry, with experience across product development and manufacturing engineering, clinical development, and regulatory affairs.
Mr. Goodson joined Aptus from AngioDynamics, Inc. (ANGO), where he held the role of Director of Scientific Affairs and Technology. Following AngioDynamics ' acquisition of FlowMedica, Inc. Mr. Goodson was a member of the founding team at FlowMedica, where he developed novel drug-device combination products to address acute kidney injury.
Prior to joining FlowMedica, Mr. Goodson held various product development engineering roles at the Cleveland Clinic Foundation, World Medical/Medtronic AVE, and Cordis Neurovascular. In his research position at the Cleveland Clinic, Mr. Goodson was involved with EVAR and thrombolysis device and intellectual property development within the Vascular Surgery department. In his roles at Medtronic AVE and World Medical, he was directly involved in engineering development for the Talent AAA stent grafts and delivery systems. Mr. Goodson began his medical device career in new product development at Cordis, where he developed catheters, guide wires, and embolic products for the interventional neurovascular market.
Mr. Goodson is a named inventor on more than 15 US and foreign issued patents. He holds a BS in Biomedical Engineering from Duke University.